IBDEI0JQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8876,0)
 ;;=B97.89^^39^403^96
 ;;^UTILITY(U,$J,358.3,8876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8876,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,8876,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,8876,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,8877,0)
 ;;=B97.10^^39^403^24
 ;;^UTILITY(U,$J,358.3,8877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8877,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,8877,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,8877,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,8878,0)
 ;;=B34.9^^39^403^97
 ;;^UTILITY(U,$J,358.3,8878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8878,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,8878,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,8878,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,8879,0)
 ;;=A69.20^^39^403^53
 ;;^UTILITY(U,$J,358.3,8879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8879,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,8879,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,8879,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,8880,0)
 ;;=A69.22^^39^403^55
 ;;^UTILITY(U,$J,358.3,8880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8880,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,8880,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,8880,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,8881,0)
 ;;=A69.21^^39^403^54
 ;;^UTILITY(U,$J,358.3,8881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8881,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,8881,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,8881,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,8882,0)
 ;;=A69.29^^39^403^20
 ;;^UTILITY(U,$J,358.3,8882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8882,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,8882,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,8882,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,8883,0)
 ;;=A69.23^^39^403^5
 ;;^UTILITY(U,$J,358.3,8883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8883,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,8883,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,8883,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,8884,0)
 ;;=A51.0^^39^403^32
 ;;^UTILITY(U,$J,358.3,8884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8884,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,8884,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,8884,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,8885,0)
 ;;=A52.3^^39^403^57
 ;;^UTILITY(U,$J,358.3,8885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8885,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,8885,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,8885,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,8886,0)
 ;;=A52.10^^39^403^56
 ;;^UTILITY(U,$J,358.3,8886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8886,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,8886,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,8886,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,8887,0)
 ;;=A52.9^^39^403^52
 ;;^UTILITY(U,$J,358.3,8887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8887,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,8887,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,8887,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,8888,0)
 ;;=A53.9^^39^403^84
 ;;^UTILITY(U,$J,358.3,8888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8888,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,8888,1,4,0)
 ;;=4^A53.9
